Jamie Wood, MD, explains how the FDA approval of Afrezza for children aged 6 years and older adds a new mealtime insulin option, offering flexibility beyond injections and pumps.
Jamie Wood, MD
Advertisement
Jamie Wood, MD, is a pediatric endocrinologist at UH Rainbow Babies & Children's Hospital.
Articles by Jamie Wood, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Top 5 pediatric health headlines you missed in May 2026
3
Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD
4
Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa
5